The 16th Congress of European Crohn's and Colitis Organisation, ECCO 2021

Among the highlights of the 2021 Scientific Programme are topics like direct comparison and combination of drugs. In 2021, we should be able to determine the role of artificial intelligence in IBD, to choose the safest therapeutic option in an era of multiple medications and to tailor therapeutic strategies to patients' profile such as age.